156 related articles for article (PubMed ID: 26358292)
1. Misfolded opsin mutants display elevated β-sheet structure.
Miller LM; Gragg M; Kim TG; Park PS
FEBS Lett; 2015 Oct; 589(20 Pt B):3119-25. PubMed ID: 26358292
[TBL] [Abstract][Full Text] [Related]
2. Misfolded rhodopsin mutants display variable aggregation properties.
Gragg M; Park PS
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2938-2948. PubMed ID: 29890221
[TBL] [Abstract][Full Text] [Related]
3. Structure and function in rhodopsin: correct folding and misfolding in two point mutants in the intradiscal domain of rhodopsin identified in retinitis pigmentosa.
Liu X; Garriga P; Khorana HG
Proc Natl Acad Sci U S A; 1996 May; 93(10):4554-9. PubMed ID: 8643442
[TBL] [Abstract][Full Text] [Related]
4. Detection of misfolded rhodopsin aggregates in cells by Förster resonance energy transfer.
Gragg M; Park PS
Methods Cell Biol; 2019; 149():87-105. PubMed ID: 30616829
[TBL] [Abstract][Full Text] [Related]
5. Wild-type opsin does not aggregate with a misfolded opsin mutant.
Gragg M; Kim TG; Howell S; Park PS
Biochim Biophys Acta; 2016 Aug; 1858(8):1850-9. PubMed ID: 27117643
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screening assays to identify small molecules preventing photoreceptor degeneration caused by the rhodopsin P23H mutation.
Chen Y; Tang H
Methods Mol Biol; 2015; 1271():369-90. PubMed ID: 25697536
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of rhodopsin retinitis pigmentosa and the efficacy of pharmacological rescue.
Krebs MP; Holden DC; Joshi P; Clark CL; Lee AH; Kaushal S
J Mol Biol; 2010 Feb; 395(5):1063-78. PubMed ID: 19913029
[TBL] [Abstract][Full Text] [Related]
8. Structure and function in rhodopsin: correct folding and misfolding in point mutants at and in proximity to the site of the retinitis pigmentosa mutation Leu-125-->Arg in the transmembrane helix C.
Garriga P; Liu X; Khorana HG
Proc Natl Acad Sci U S A; 1996 May; 93(10):4560-4. PubMed ID: 8643443
[TBL] [Abstract][Full Text] [Related]
9. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa.
Kaushal S; Khorana HG
Biochemistry; 1994 May; 33(20):6121-8. PubMed ID: 8193125
[TBL] [Abstract][Full Text] [Related]
10. Calnexin improves the folding efficiency of mutant rhodopsin in the presence of pharmacological chaperone 11-cis-retinal.
Noorwez SM; Sama RR; Kaushal S
J Biol Chem; 2009 Nov; 284(48):33333-42. PubMed ID: 19801547
[TBL] [Abstract][Full Text] [Related]
11. Retinitis pigmentosa mutants provide insight into the role of the N-terminal cap in rhodopsin folding, structure, and function.
Opefi CA; South K; Reynolds CA; Smith SO; Reeves PJ
J Biol Chem; 2013 Nov; 288(47):33912-33926. PubMed ID: 24106275
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological manipulation of gain-of-function and dominant-negative mechanisms in rhodopsin retinitis pigmentosa.
Mendes HF; Cheetham ME
Hum Mol Genet; 2008 Oct; 17(19):3043-54. PubMed ID: 18635576
[TBL] [Abstract][Full Text] [Related]
13. Altered functionality in rhodopsin point mutants associated with retinitis pigmentosa.
Andrés A; Garriga P; Manyosa J
Biochem Biophys Res Commun; 2003 Mar; 303(1):294-301. PubMed ID: 12646201
[TBL] [Abstract][Full Text] [Related]
14. Retinitis pigmentosa rhodopsin mutations L125R and A164V perturb critical interhelical interactions: new insights through compensatory mutations and crystal structure analysis.
Stojanovic A; Hwang I; Khorana HG; Hwa J
J Biol Chem; 2003 Oct; 278(40):39020-8. PubMed ID: 12871954
[TBL] [Abstract][Full Text] [Related]
15. Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration.
Colley NJ; Cassill JA; Baker EK; Zuker CS
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):3070-4. PubMed ID: 7708777
[TBL] [Abstract][Full Text] [Related]
16. Structure and function in rhodopsin: Mass spectrometric identification of the abnormal intradiscal disulfide bond in misfolded retinitis pigmentosa mutants.
Hwa J; Klein-Seetharaman J; Khorana HG
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4872-6. PubMed ID: 11320236
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa.
Noorwez SM; Kuksa V; Imanishi Y; Zhu L; Filipek S; Palczewski K; Kaushal S
J Biol Chem; 2003 Apr; 278(16):14442-14450. PubMed ID: 12566452
[TBL] [Abstract][Full Text] [Related]
18. Aggregation of rhodopsin mutants in mouse models of autosomal dominant retinitis pigmentosa.
Vasudevan S; Senapati S; Pendergast M; Park PS
Nat Commun; 2024 Feb; 15(1):1451. PubMed ID: 38365903
[TBL] [Abstract][Full Text] [Related]
19. The co-chaperone and reductase ERdj5 facilitates rod opsin biogenesis and quality control.
Athanasiou D; Bevilacqua D; Aguila M; McCulley C; Kanuga N; Iwawaki T; Chapple JP; Cheetham ME
Hum Mol Genet; 2014 Dec; 23(24):6594-606. PubMed ID: 25055872
[TBL] [Abstract][Full Text] [Related]
20. Clearance of Rhodopsin(P23H) aggregates requires the ERAD effector VCP.
Griciuc A; Aron L; Piccoli G; Ueffing M
Biochim Biophys Acta; 2010 Mar; 1803(3):424-34. PubMed ID: 20097236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
